These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 36239905)
61. Recalcitrant molluscum contagiosum successfully treated with the pulsed dye laser. Omi T; Kawana S Laser Ther; 2013; 22(1):51-4. PubMed ID: 24155550 [TBL] [Abstract][Full Text] [Related]
62. Cantharidin therapy for molluscum contagiosum in children. Epstein E J Am Acad Dermatol; 2001 Oct; 45(4):638. PubMed ID: 11568766 [No Abstract] [Full Text] [Related]
63. Comparison Of Efficacy Of 10% Potassium Hydroxide Solution Versus Cryotherapy In Treatment Of Molluscum Contagiosum. Qureshi A; Zeb M; Jalal-Ud-Din M; Sheikh ZI; Alam MA; Anwar SA J Ayub Med Coll Abbottabad; 2016; 28(2):382-385. PubMed ID: 28718569 [TBL] [Abstract][Full Text] [Related]
64. Patient demographics and utilization of health care services for molluscum contagiosum. Molino AC; Fleischer AB; Feldman SR Pediatr Dermatol; 2004; 21(6):628-32. PubMed ID: 15575844 [TBL] [Abstract][Full Text] [Related]
65. An update on the clinical management of cutaneous molluscum contagiosum. Nguyen HP; Tyring SK Skin Therapy Lett; 2014; 19(2):5-8. PubMed ID: 24740746 [TBL] [Abstract][Full Text] [Related]
66. An open, nonrandomized, comparative study of imiquimod 5% cream versus 10% potassium hydroxide solution in the treatment of molluscum contagiosum. Metkar A; Pande S; Khopkar U Indian J Dermatol Venereol Leprol; 2008; 74(6):614-8. PubMed ID: 19171985 [TBL] [Abstract][Full Text] [Related]
67. Treatment of molluscum contagiosum: a brief review and discussion of a case successfully treated with adapelene. Scheinfeld N Dermatol Online J; 2007 Jul; 13(3):15. PubMed ID: 18328209 [TBL] [Abstract][Full Text] [Related]
68. Ken and Katie caterpillar: helpful props for treatment of molluscum contagiosum. Silverman RA; Lucky A Pediatr Dermatol; 2003; 20(3):279-80. PubMed ID: 12787284 [TBL] [Abstract][Full Text] [Related]
69. Cantharidin: a valuable office treatment of molluscum contagiosum. Funt TR; Mehr KA South Med J; 1979 Aug; 72(8):1019. PubMed ID: 472800 [TBL] [Abstract][Full Text] [Related]
70. Treatment of facial molluscum contagiosum with trichloroacetic acid. Bard S; Shiman MI; Bellman B; Connelly EA Pediatr Dermatol; 2009; 26(4):425-6. PubMed ID: 19689517 [TBL] [Abstract][Full Text] [Related]
71. Clinical remission of disseminated molluscum contagiosum infection in a patient with atopic dermatitis treated with dupilumab. Elosua-González M; Rosell-Díaz Á; Alfageme-Roldán F; Sigüenza-Sanz M; Roustan-Gullón G An Bras Dermatol; 2022; 97(3):358-361. PubMed ID: 35307242 [TBL] [Abstract][Full Text] [Related]
72. How and when to treat molluscum contagiosum and warts in children. Smolinski KN; Yan AC Pediatr Ann; 2005 Mar; 34(3):211-21. PubMed ID: 15792113 [TBL] [Abstract][Full Text] [Related]
73. Two Cases of Giant Molluscum Contagiosum on the Eyelids of HIV Patients Successfully Treated with Adjuvant Self-Applied Topical 20% Potassium Hydroxide Solution. Achdiat PA; Adriyani KM; Pospos AG; Rowawi R; Hindritiani R; Suwarsa O; Gunawan H HIV AIDS (Auckl); 2021; 13():993-997. PubMed ID: 34849035 [TBL] [Abstract][Full Text] [Related]
74. Disseminated molluscum contagiosum in a HIV-positive child. Improvement after therapy with 5% imiquimod. Theiler M; Kempf W; Kerl K; French LE; Hofbauer GF J Dermatol Case Rep; 2011 Jun; 5(2):19-23. PubMed ID: 21894250 [TBL] [Abstract][Full Text] [Related]
75. Epidemiology and impact of childhood molluscum contagiosum: a case series and critical review of the literature. Braue A; Ross G; Varigos G; Kelly H Pediatr Dermatol; 2005; 22(4):287-94. PubMed ID: 16060861 [TBL] [Abstract][Full Text] [Related]
76. Molluscum Contagiosum: Review and Update on Management. Forbat E; Al-Niaimi F; Ali FR Pediatr Dermatol; 2017 Sep; 34(5):504-515. PubMed ID: 28884917 [TBL] [Abstract][Full Text] [Related]
77. COVE-1: A Phase 2, Open-Label Study to Evaluate Efficacy and Safety and the Optimal Regimen of VP-102, a Proprietary Drug-Device Product Containing Topical Cantharidin (0.7% w/v) Under Occlusion for the Treatment of Common Warts. Guenthner S; McFalda W; Kwong P; Eads K; McCafferty M; Rieger J; Glover DK; Willson C; Burnett P; Olivadoti M Dermatol Ther (Heidelb); 2021 Oct; 11(5):1623-1634. PubMed ID: 34286459 [TBL] [Abstract][Full Text] [Related]